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New Haven, CT. 
Abstract 
The expression of the secondary granule protein (SGP) genes lactoferrin (LF), 
transcobalamin (TBI), human neutrophil gelatinase (HNG) and collagenase (HNC) is 
coordinately regulated at the level of mRNA transcription. Our laboratory has 
previously identified a silencer element in the LF promoter which binds CCAAT 
displacement protein (CDP); when CDP is overexpressed in myeloid cells, it blocks the 
expression of all SGP genes. CDP is a ubiquitous repressor known to be implicated in 
the regulation of many myeloid-specific genes, and we wish to determine the means by 
which it acts as a stage specific repressor of multiple genes at different stages of 
differentiation. Here we describe the cloning, sequencing and partial characterization of 
the 5' flanking region ot the Mouse Neutrophil Collagenase (MNC) gene. The MNC 
promoter shows a high degree of conservation over more than 200bp with the human 
homolog, with a 56bp stretch sharing 81.4% nucleotide identity. Within this region, we 
have identified well described control elements involved in myeloid gene regulation, 
including a canonical consensus sequence for the CCAAT enhancer binding protein 
alpha (C/EBPa). Functional assays will be necessary to establish the functional 
significance of these regions. CDP binding sites are highly promiscuous and can only be 
characterized functionally. The identification of the promoter will now allow such 
characterization. 
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I. OVERVIEW OF TRANSCRIPTIONAL REGULATION OF MYELOID 
DIFFERENTIATION 
Hematopoiesis is the process by which blood cells acquire defining phenotypes 
as the consequence of coordinated, cell-specific gene expression. The proliferation and 
differentiation of hematopoietic cells are orchestrated by a variety of extra and intra 
cellular signals. Extracellular signals, namely growth factors, signal cellular events by 
binding membrane and cytoplasmic receptors. They produce their physiologic effect by 
modulating the level of expression of key transcriptional regulators and directing 
downstream changes in proliferation and phenotype by regulating gene expression. 
The regulation of gene expression is mediated through ds-acting regulatory 
sequences and the trans-acting regulatory factors which bind to them. The locus of 
biological activity of these regulatory elements is usually at the 5' flanking region of the 
transcription start site of the genes, namely the promoter. 
The pathway to terminal neutrophil differentiation and maturation has not been 
completely outlined. However some of the necessary transcriptional regulators 
governing that process are emerging out of recent studies. 
PU.l appears to be required for myeloid differentiation. PU.l is the product of 
Spi-l/Sfpil/PU.l protooncogene, a hematopoietic-specific member of the ets family 
expressed principally in monocytes, macrophages and B lymphocytes, but also in 
granulocytes and erythroid cells. Nearly all myeloid-specific genes contain biologically 
active PU.l binding sites in their regulatory regions. In one study, mice lacking PU.l 
function die 1 to 3 days before their expected birth and these PU. 1-null mice show an 
absence of monocytes, T and B lymphocytes and granulocytes. Further, flow cytometry 
shows diagnostic Ig and T cell receptor gene rearrangements1, as demonstrated by 
surface markers. Early myeloid-specific genes are expressed in embryonal stem cells 
from these mice. These cells in fact show a loss of all late markers of lymphoid and 

2 
myeloid lineage maturation2 3. Another study of PU. 1-null mice results in viable mice 
with an otherwise similar defect in myeloid cell development. For example, granulocyte- 
colony stimulating factor (G-CSF) and granulocyte macrophage-colony stimulating 
factor (GM-CSF) receptor mRNA can be detected in these cells. However these 
receptors are not detected at the protein level. The reasons for the discordant viability 
of the two models are unknown. 
Also implicated in early myeloid differentiation is the family of CCA AT/ 
Enhancer binding proteins (C/EBP)4. Shown to be a member of a family of differentially 
expressed genes, C/EBP was first isolated as a protein with a basic region/leucine 
zipper structure which binds a CCAAT site. It was originally purified and cloned from 
rat liver and appears to have a role in adipogenesis. C/EBPa-null mice have an 
impaired glucose metabolism and die within 24 hours of birth. Late myeloid 
differentiation is also impaired in these mice as they show absence of mature 
granulocytic cells, and very low expression of the G-CSF receptor5 6. 
Other transcription factors important for myeloid differentiaion include MZF- 
l7'8, c-myb9, and the retinoic acid receptors10. The evidence is growing that there are 
complexes of transcription factors which are necessary for regulated expression of many 
of the myeloid genes. 
In order to understand leukemogenesis and normal myeloid differentiation it is 
important to identify and characterize cis and trans regulators that activate important 
genes in the myeloid lineage. 
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II. SECONDARY GRANULE PROTEIN GENE EXPRESSION IN NEUTROPHILS. 
In the process of differentiation and maturation of neutrophils, a critical and 
pivotal step occurs at the transition from promyelocytes to myelocytes. Normal 
progenitor marrow cells begin to lose proliferative capacity11 as they become committed 
to terminal neutrophil maturation12. Leukemic cells from patients with AML are 
arrested in maturation at or before the promyelocyte stage, suggesting the critical 
importance of understanding the processes involved in regulating this commitment 
step. 
Sequential phases of granulocyte differentiation show the acquisition of different 
types of granules. The promyelocyte stage is marked by primary ("nonspecific") 
granules which are attenuated in the later stages of both neutrophil and monocyte 
maturation13. As a promyelocyte advances to the myelocyte stage it acquires secondary 
("specific") granules14. Specific granules carry four major identified proteins, namely, 
transcobalamin I (TCI), lactoferrin (LF), human neutrophil collagenase (HNC), and 
human neutrophil gelatinase (HNG). The rise of secondary granules provides a unique 
label of commitment to terminal neutrophil differentiation. Thus, the expression of 
genes responsible for the formation of secondary granule membranes and their contents 
should constitute a convenient probe for the mechanisms governing regular neutrophil 
differentiation. 
HNG and HNC are believed to be responsible for the turnover of extracellular 
matrix and involved in the acquisition of metastatic potential in transformed cells. Our 
laboratory has previously cloned and sequenced approximately lkb of the 5'flanking 
region of the human neutropil collagenase gene (See Figure 1). This promoter has not 
been characterized functionally. 
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Under physiologic conditions, collagenases are enzymes that cleave peptide 
bonds in the triple-helical regions of collagen. Two sets of collagenases are known: the 
tissue collagenases and the collagenases implicated in gas gangrene. 
The bacterium Clostridium histolyticum that causes gas gangrene secretes a 
battery of collagenases that contribute to their invasiveness by destroying the 
connective-tissue barriers of the host. 
Neutrophil collagenase is a tissue collagenase and is thought to play a role in 
degrading collagen in inflammation. The action of the collagenases is potentially 
harmful to the host but activated collagenases can be inhibited by a family of specific 
tissue inhibitors produced by most mesenchymal cells. Neutrophil collagenase probably 
plays a critical role in the host response to infection as well as in conferring metastatic 
potential in malignancy. 
A.)Secondary granule protein gene transcription is coordinately regulated at the level 
ofmRNA transcription. 
Studies in several systems have shown that secondary granule protein gene 
(SGP) expression is coordinately regulated at the level of mRNA transcription. 
Upon induction with G-CSF the 32Dcl3 cell line (32D) undergo differentiation to 
mature neutrophils. The 32D cell line is a murine stem cell line that requires IL3. The 
Berliner laboratory proved that upon induction of neutrophil differentiation with G- 
CSF, the expression of a mouse neutrophil gelatinase gene showed a similar pattern to 
that of the LF gene. Nuclear run-on assays established that regulation of expression was 
transcriptional15. Our laboratory later isolated a cDNA clone for the mouse homolog of 






















Figure. 1 - DNA sequence of the 5' Flanking region of HNC gene. Capitalized 
sequence corresponds to transcribed region as intimated by cDNA data. 
Region of conservation with the mouse homolog is italicized, with highest 
conservation in bold faces. Translation start site is underlined. 
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MPRO cells are derived from murine bone marrow stem cells which have been 
retrovirally transduced with a dominant negative retinoic acid receptor (RARa) by Tsai 
et al. who described two cell lines from such transductions: a stem cell factor-dependent 
cell line, EML, which fails to differentiate into early myeloid precursors until treated 
with all trans retinoic acid (ATRA), and a GM-CSF dependent line, MPRO, which is 
blocked in differentiation at the promyelocyte stage. Our laboratory has induced 
neutrophil differentiation in both EML and MPRO with appropriate growth factors in 
the presence of ATRA, and has shown phenotypic maturation to mature neutrophils 
associated with rapid increase in LF gene expression . 
In further studies, the laboratory examined the sequential expression of the 
primary and secondary granule protein genes in purified bone marrow progenitors 
induced with cytokines to undergo in vitro differentiation to terminal neutrophils. Over 
a period of 10-12 days, the cells progressively matured to the late metamyelocyte and 
band stage. Induction with G-CSF resulted in a stage-specific expression of primary and 
secondary granule proteins, with asynchronous expression of nonspecific granule 
proteins starting from days 1-5, and concommitant expression of lactoferrin and 
transcobalamin I (SGPs) from day 7-817. 
B.)SGPgene expression is coordinately blocked in abnormal myeloid differentiation 
Leukemic cell lines proliferate independently from growth factors. The HL60 
and NB4 cell lines were derived from patients with acute promyelocytic leukemia and 
are used in the study of neutrophil differentiation. Our laboratory has shown an 
irreversible block to SGP gene expression in inducible leukemic cells 
HL60 cells are inducible to phenotypic maturation with 12-0- 
tetradecanoylphorbol-13-acetate (TPA) to monocytes and with dimethyl sulfoxide 
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(DMSO) to granulocytes. HL60 cells induced with DMSO undergo defective neutrophil 
maturation, manifested by a coordinate loss of secondary granule protein gene 
expression. In previous studies our laboratory has characterized the defect in secondary 
granule protein gene expression in uninduced and DMSO-induced HL60 cells. Nuclear 
run-on assays confirmed that the secondary granule protein mRNA are not transcribed. 
In addition, our laboratory has sequenced more than 600bp of the HL60 lactoferrin 
promoter region and shown that it is not defective structurally. Since the SGP genes are 
not linked these results suggest that the failure of gene expression in these cells reflects a 
regulatory defect in part via a trans-acting factor18. 
Similar findings have been shown in the NB4 cell line which exhibits a defect in 
granulocytic maturation in ATRA-induced cells. They lack expression of all the 
secondary granule protein genes upon induction with ATRA19. 
Further, specific granule deficiency (SGD), is a congenital disorder characterized 
by recurrent infections, the absence of neutrophil secondary granules, and marked 
deficiency or absence of their content proteins. We demonstrated insignificant mRNA 
levels for all of the secondary granule protein genes as well as for defensins from bone 
marrow cells obtained from a patient with SGD. These levels were comparable to the 
previous SGP levels measured in this patient's neutrophils. This is consistent with the 
notion that a common frans-acting factor governing secondary granule protein gene 
expression may be compromised in SGD20,21'. 
Finally, studies of patients with newly-diagnosed acute leukemia have shown 
absence and/or abnormalities in secondary granule protein gene expression in 
apparently normal neutrophils which are actually part of the malignant clone. 
In light of these studies our laboratory hypothesizes that one irregularity of the leukemic 
cell is a compromise of the differentiation program via common cis and trans acting factors 
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which interrupts later events in neutrophil maturation, as reflected in the coordinate loss of 
expression of secondary granule proteins. 
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III. IDENTIFICATION OF A SHARED REGULATORY PATHWAY FOR MULTIPLE 
MYELOID-SPECIFIC GENES. 
A) Identification of a silencer within the LF promoter 
The LF promoter has been extensively studied in our laboratory. LF promoter 
sequences spanning -384, -649, -726,-750, -800, and -916 bp upstream of the LF 
transcription start site were subcloned into the pGL2 promoterless vector. These 
constructs were assayed by transient transfection into many leukemic hematopoietic 
cell lines including K562, a cell line isolated from a patient with CML in blast crisis, and 
HEL, a human erythroleukemia cell line; these leukemic lines do not express LF. These 
plasmids were also assayed in the uninduced 32Dcl3, the IL-3 dependent murine 
myeloid progenitor cell line mentioned earlier, which expresses the LF gene only after 
G-CSF-induced differentiation. Measurable luciferase activity was detected for the -384, 
-649, -726,-750 and -800bp constructs. These results were duplicated in HeLa cells, a 
non-hematopoietic cell line. However, the -916bp construct only expressed background 
levels of activity suggesting the presence of a silencer between the 800bp and 916bp 
upstream of the LF gene transcription start site40. 
Our laboratory has subsequently shown that the silencing effect is mediated by a 
nucleotide sequence containing a triad of octamers reported below: 
5' ATGTATTTACGAGATGTATTCTAGAAGCAGTATTCTAGCTTTTGAATTTT 3’ 
Deletion plasmids where a 56bp sequence containing the triad of octamers was 
removed expressed levels of luciferase activity comparable to the -726bp suggesting that 
the 56bp deleted fragment is a cis-acting silencer of LF expression. 
B) Identification of CDF as binding protein for silencer element: 
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Our laboratory has studied the identified silencer element for DNA-protein 
interactions by mobility shift assays and UV crosslinking. Data from these studies 
confirm the presence of a large protein-DNA complex (180kD protein) in LF non¬ 
expressing cells40 which is absent from LF expressing cells. This has been shown to be 
bound by CCA AT displacement protein (CDP/cut) described more extensively below. 
To further establish the role of CDP in LF gene expression Khanna-Gupta et al. 
isolated 32D cells stably transfected with a CDP expression vector. Tissue cultures of 
transfected cells, and single cell clones overexpressing CDP show a complete loss of LF 
mRNA upon induction with G-CSF, while these cells maintain the ability to undergo 
morphologic differentiation. Remarkably, CDP overexpression also prevents the 
expression of neutrophil gelatinase, neutrophil collagenase, and of the myeloid specific 
gene gp91 phox (Figure 2)39'40. 
The coordinate loss of secondary granule protein gene expression upon 
overexpression of CDP intimates that the coordinate loss of SGP expression in leukemia 
and SGD could reflect an irregularity of modulation of CDP binding and/or CDP 
expression. In light of the fact that CDP has been shown to interact with a variety of 
myeloid specific genes, including PU.l, our laboratory postulates that modifications in 
CDP binding may be crucial to stage-specific gene expression throughout the process of 
myeloid differentiation. 
An understanding of how CDP interacts with different genes at different phases 
of the maturation program may therefore provide critical insights into the process of 
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Figure 2.- Northern Blot showing suppression of SGP gene expression in 32D cells 
(Courtesy of Nathan Lawson. See reference 38. 
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IV. CDP AND POSITIVE REGULATORS IN MYELOID PROMOTERS. 
Tissue-specific control of gene expression appears to be partly mediated by 
negative regulatory elements as exemplified in the growth hormone22, MHC23,and 
lysozyme24 gene systems. These systems uniformly exhibit tightly regulated expression 
that is tissue and stage specific, as with the repression of the lysozyme gene in the stages 
prior to myeloid differentiation25, and the suppression of immunoglobulin gene 
expression in immature pre-B cells26. 
Originally described as a repressor of the sea urchin testis-specific H2B gene 
promoter27, CDP is constitutively expressed in most cells. CDP is a member of a 
homeodomain family involved in lineage specification. This family incudes the 
Drosophila cut protein and CDP is related to the canine clox18 (Cut like homeobox) and 
murine cwx-129'30'31. CDP/cut proteins contain four possible DNA-binding motifs with 
overlapping but distinct sequence specificities32, but often binds specifically to disparate 
sequences. 
The role of CDP has been demonstrated in the repression of a wide variety of 
genes including the human myeloid-specific cytochrome b558 heavy chain gene, gp91 
phox, the human c-myc gene33, human y-globin gene, mouse NCAM gene, and mouse 
myosin heavy-chain gene. Recent studies of the interaction of CDP with the histone 
gene locus would lead one to infer that it is a part of a complex with Rb, and may have a 
critical role in modulating cell cycle events34. 
The control of gene expression is usually dependent on a complex interplay of 
positive and negative regulatory factors. For example, although constitutively 
expressed in myeloid cells, CDP shows decreased binding for preferential binding of 
CCAAT enhancer protein, and resultant gp91-phox expression in maturing 
neutrophils35'36. There is growing evidence that such a complex interaction is central to 
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the regulation of myeloid specific genes, especially of the myeloid cytokine receptors. 
As mentioned earlier binding of PU.l appear to be required for myeloid gene 
activation4,5. Another group of positive regulators, namely the C/EBP factors also 
appear to be major modulators of myeloid gene expression with binding sites often 
proximal to PU.l binding elements. All C/EBP genes are activated in myeloid 
differentiation with relative abundance of the different proteins. In addition to PU.l and 
C/EBP, the AML1 transcription factor seems necessary for optimal myeloid promoter 
function. Mutation of AML1 binding site has been shown to dramatically decrease 
myeloid promoter function4537. 
Tissue-specific gene expression is likely to be highly complex and tightly 
orchestrated by the positive and negative arms of regulation. We hypothesize that CDP 
plays an integral role in this complex interaction. 
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V. STATEMENT OF PURPOSE 
With the aim of further characterizing the spectrum of CDP-regulated genes and 
the means by which it acts as a stage specific repressor of multiple genes we have 
endeavored to identify and sequence the mouse neutrophil collagenase promoter and 
compare it to the LF and HNC promoters. 
We propose that one of the ways CDP may mediate its effects is through common 
cis-acting elements in the promoters of its target genes. 
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VI. MATERIALS AND METHOD 
A. Cell lines and Cloning of the full length MNC cDNA. (done by Nathan Lawson) 
The EML line, a murine stem cell line, is stem cell factor (SCF)-dependent, 
multipotential, and displays a specific block to differentiation along the myeloid lineage 
with SCF and IL3. When induced with IL3 and SCF in the presence of high doses of all- 
trans retinoic acid (ATRA), EML cells differentiate to promyelocytes. Transfer to GM- 
CSF in the presence of ATRA will promote full differentiation to neutrophils. MPRO 
cells were selected for growth in GM-CSF, and are blocked in differentiation at the 
promyelocyte stage. When induced with ATRA, they too will mature to neutrophils. 
Induction of EML with IL3, SCF, and ATRA for three days, followed by culture in GM- 
CSF in the absence of ATRA results in a cell line blocked at the promyelocyte stage. This 
line, termed EPRO, is similar in phenotype to the MPRO cell line. Using cDNA 
representational difference analysis to compare the EPRO cell line to the multipotent 
stem cell line from which it was derived, EML, our laboratory had previously isolated a 
full length 1.9 kb MNC cDNA. That fragment was subsequently cloned in pBluescript 
(Stratagene, LaJolla,CA) vector. 
B. Generation of a probe for screening a genomic library. 
The above construct was used to transform DH 10B electromax cells according to 
standard protocol. The transformed cells were lysed by alkali and the amplified clone 
was isolated by ultracentrifugation, CsCl/EtBr gradients according to standard 
protocol.. The product was digested with appropriate restriction enzymes and purified 
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on an agarose gel. The 1.9 kb MNC cDNA was radiolabelled by nick translation and 
used as a probe to screen the 129 SV mouse genomic library which was kindly provided 
by Dr. Archibald Perkins. 
C. Titering of library. 
Phage were diluted in SM (NaCl 5.8g/L;MgS04/7H20 2.0 g/L; 1M Tris,pH 7.5 
50ml/L;2% Gelatin 5ml/L) to estimated concentrations of 103,104, and 105/ml and plated 
on small NZY agar plates with l-2gl/plate. 100 |il of overnight host bacteria, LE 392, 
were adsorbed to phage at 37°C for 15 minutes, diluted in 3ml of molten agarose and 
poured onto warmed plates which were subsequently incubated at 37°C overnight. 
Plaques were subsequently counted to determine phage titer. 
D. Screening of 129SVgenomic library. 
Phages were plated at 10b plaque forming units (pfu)/plate and 30 plates were 
used to screen approximately 1.5xl06 recombinants. Host bacteria were adsorbed to 
phages at 300|il/plate at 37°C for 30 minutes prior to overnight incubation. Duplicate 
BioTraceNT nitrocellulose membranes (Gelman Sciences, Ann Arbor, MI) were lifted 
and hybridized at 65°C overnight to the nick-translated MNC cDNA probes in 
hybridization solution (4xSSC;5x Denhardt's;.l% SDS; salmon sperm DNA; 0.1% Na 
pyrophosphate) and washed with 2xSSC(300mmol/L NaCl,60 mmol/L NaCitrate)/0.5% 
SDS twice at room temperature for 5 minutes followed by 15 min. of washing in 
2xSSC/0.1% SDS at room temperature and finally one high stringency wash in 
0.5xSSC/0.1% SDS at 65°C for 30 min.. Films were exposed for 48 hrs. for visualization 
of positive plaques. Positive plaques were purified by secondary and tertiary screenings 
using the above method. 
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E. Phage amplification. 
The tertiary core phage was titered as described above and the phage were 
plated on NZY agarose plates at lxlO5 pfu/plate and grown overnight at 37°C for 
confluent lysis. The small plates were then overlayed with 9ml of SM and gently shaken 
at room temperature overnight. The SM was then collected spun and the supernatant 
stored. Tertiary phages were thus amplified to 109 pfu/plate. The phagemids were 
subsequently excised according to standard protocol and digested by several restriction 
enzymes. Genomic fragments were subcloned into the pbluescript plasmid vector. 
F. Generation of probes for isolation of 5' region of the MNC gene.. 
The 1.9 kb MNC cDNA was digested with appropriate enzymes to generate a 
500bp probe for the 5' portion of the MNC cDNA. That fragment was subsequently 
radiolabelled by Nick translation as described above. That probe was used for initial 
screening of genomic clones and preliminary sequences obtained were used to generate 
upstream genomic oligonucleotides. These 3:P labeled 22-24bp single stranded 
oligonucleotides, including one corresponding to the 5' end of the MNC cDNA were 
used for further screening of genomic clones. 
G. Isolation of the 5' flanking region of the MNC gene. 
The genomic constructs were used to transform DH 10B electromax cells by 
electroporation. Transformed cells were plated and incubated overnight at 37°C. 
Nitrocellulose filters (Gelman Sciences, Ann Arbor,MI) were lifted and hybridized at 
37°C overnight to the probes described above. Positive colonies were grown and lysed 
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according to Qiagen Maxi protocols and plasmids were isolated and submitted to the 
Yale sequencing facility for sequencing by the dideoxy chain termination method. 
H. Analysis of sequences. 




A. Isolation of the MNC gene. 
Using the 129 SV genomic library, approximately 1.5xl06 phages were screened 
with the 1.9kb MNC cDNA resulting in 17 positive clones. From these 5 clones were 
purified by secondary and tertiary screens. 
B. Isolation of the 5' flanking region of the MNC gene. 
Two of the 5 positive clones were digested and subcloned in pBluescript and 
screened with the 500bp MNC cDNA corresponding to the 5' region and sequenced. 
These sequences were used to design single stranded oligonucleotides, including one 
corresponding to the 5' end of the MNC cDNA, with which to obtain further upstream 
sequences. 
5 subclones were isolated, representing three independent DNA fragments. Two 
of these clones were identical, 5kb in size , and contained the first exon of the MNC gene 
and 4kb of the 5' flanking region. Two other identical clones (1.8kb) contained most of 
the first intron and part of the second exon. We have subsequently established the first 
intron to be l,839bp in length. The last positive clone was found to be a subclone of the 
latter two clones (Figures 3 & 4). 
Previous studies of the MNC cDNA have established the translation start site 
and suggested a relatively short 5' untranslated (UTR) region of 73 nucleotides. It 
remains to be determined by SI nuclease and primer extension if there is additional 5' 




The clone containing the 5' flanking region was digested with several resriction 
enzymes and a map of that region was generated (Figures 6,7 & 8). 
4 
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Figure 3.- Pst digests of two positive subciones. The subclones are identical in size 
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Figure 4 - EcoRI/HindlH digests of three positive subclones. Two are identical in size and contain the 
genomic subfragment with the first intron of the MNC gene. 
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C. Sequence analysis of the 5'flanking region of the MNC gene. 
Sequence of 1314bp 5' of the putative transcription start site as well as 1839bp of 
the first intron was obtained(Figure 5) Analysis of the sequence at the 5' end of the 
MNC gene shows several well-described control sequences. A CCAAT element is 
found at -6 as well as an AP.l recognition site at that position. There is a c-myb binding 
element at -111, a CACCC motif at -200 and a PU.l binding site at -253. A C/EBPa 
binding site is found in the reverse direction at -530 and further upstream a C/EBP(3 
element is found at -772 . Multiple binding sites for the zinc-finger transcription factor 
GATA-1 are at -796, -1038, and -1169 as well as a TGGCA element at -1000. Finally we 
found at -1269 and at -1221 consensus sequences to the c-ets-2 and c-ets-1 binding 
factors. 
The sequence between -125 and -69 shows a high degree of sequence 
conservation with the human homolog of neutrophil collagenase. That region shares a 
81.4% similarity index with a region in the 5' flanking region of the human neutrophil 
collagenase (Figure 9). In the human counterpart that region contains a canonical 
consensus binding site for C/EBPa whereas the sequence in the mouse genome is 
imperfect. Further the region spanning 254bp upstream of the 5' untranslated region 
maintains a high degree of conservation, sharing a 71.1% simlarity index with the 
corresponding region in the promoter of the human neutrophil collagenase. The role of 
this region in regulating MNC expression is not yet established but the high 
conservation in regions that do not encode protein suggests that it may be important. 
No comparative octamer repeats, namely a negative regulatory element, to the 
LF promoter were found in our preliminary analysis and sequence. This is probably not 



























Figure 5.- Sequence of 5' Flanking region of MNC gene. Well described 
control elements are illustrated. Exon is in capitals. Region of high 
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Figure 6.- Restriction map of 5' flanking region of MNC gene. 
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Figure 7 - Restriction digests of plasmid construct containing the 5kb insert. The 
cloning site is Pst and our molecular weight standard was Lambda DNA cut with 
Hindlll and PhiX174 with Haeill. 
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Figure 8.- Restriction digests of plasmid construct containing the 5kb insert. The cloning 
site is Pst and our molecular weight standard was Lambda DNA digested with Hindi 11 
and PhiX174 cut with Haelll. 
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c-myb; C/EBPc/. binding element 
5' _ Humn 3' 
AAATCAGA3TTATAAAATKX!AAAACIUK^ 
IIIIIIIIII III IIII I IIIIIIIIIIIII II IIIIIIIII IIIII 
AAATCACAITCTAACATTGAAGAACTGT^ 
5' Mouse 3' 
Figure 9.- Region of 81.4% identity in human and mouse 
neutrophil collagenase promoters. This region is 
italicized and in bold faces in the complete sequences 




We report here the cloning of the 5' flanking region of the MNC gene, the first 
exon and the first intron (data not shown) as well as mapping studies of 4kb of the 
promoter of the MNC gene. We further report preliminary characterization of cis-acting 
5' promoter sequences. 
Our studies have been aimed at understanding the role of CDP in regulating 
the MNC gene within the context of the neutrophil secondary granule proteins. It has 
already been shown that CDP overexpression blocks the expression of all SGP genes 
including the MNC gene38. It is postulated that a disruption in early myeloid 
differentiation mediates continued binding of CDP and thereby blocks SGP gene 
expression in abnormal myeloid differentiation. 
The silencer element identified in the LF promoter is highly conserved 
between the mouse and human LF. The overall homology at the nucleotide level 
between the human and mouse LF promoters in this region is 82.5% with conservation 
of the octamer repeats suggesting a high functional importance in regulating gene 
expression39 Our preliminary results suggest that CDP recognizes a different sequence in 
the MNC promoter, pending further upstream sequencing. This is not surprising since 
CDP lacks a well defined consensus binding sequence. Studies by Liu and Skalnik35,36'40 
have shown differential affinity for the different DNA binding domains of CDP for 
different sites within the gp91 phox promoter. Furthermore, association of recombinant 
proteins through their GST portions increased binding affinity, suggesting that DNA 
binding activity is enhanced by potential interactions of different binding domains 
binding to different regions of the promoter40. A putative silencer within the MNC 
promoter should be sought. 
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The role of the cis—acting sequence elements in the regulation of MNC remains 
to be established with physiologic studies. However several are of potential interest. 
The transcription start site has not yet been mapped but perhaps the most 
important cis regulating elements lie within the 254 bp upstream of the untranslated 
region which share a high degree of conservation with the HNC promoter. As 
mentioned earlier that region corresponds to a C/EBPa canonical consensus sequence in 
the HNC promoter. Many studies suggest that in the hematopoietic system, C/EBP 
factors may be specifically expressed in myeloid cells, as indicated earlier. C/EBPa, 
C/EBP(3 and C/EBP5 have been detected in all myeloid cell lines. C/EBPa has been 
identified as the major form of these proteins that binds to the promoters of the M-CSF 
receptor and GM-CSF receptor at the a sites and trans-activate them in myeloid cell 
lines4,5. 
It has been shown that C/EBP(3 regulates the ILlj3 promoter consistent with the 
role of this member of the family in activation by cytokines like IL6 and LPS. Targeted 
disruption of C/EBP[3 leads to defects in killing of bacteria and tumor cells by 
macrophages4,5. It is not surprising to find a binding site for this transcription factor as 
one would expect an increase in MNC synthesis as part of the broader expansion of the 
granulocyte mass in the inflammatory response. 
The transcription factor PU.l has been previously indicated to be crucial for 
terminal myeloid gene expression and differentiation4 5. Most of the myeloid promoters 
lack a TATA box. They are often dependent on an SP.l site which confers specificity, 
activity and inducibility. Many of these promoters, including the MNC 5' flanking 
region, have a PU.l binding site upstream of the transcription start site. It is thought 
that PU.l activates these promoters by recruiting TATA binding protein4 \ 
Functionality of the site remains to be shown. 
Of note , many GATA-1 canonical consensus sequences as well as a c-myb 
binding site are reported, c-myb is involved in early hematopoiesis whereas GATA-1 
1 
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has a predominant role in erythropoiesis. Interestingly we did not identify an MZF-1 
element. 
In summary, we have isolated two genomic clones which together include 
4kb of the 5' flanking region of the MNC gene, the first exon and part of the second 
exon. The 5' flanking DNA contains several potential cis-acting regulatory elements 
whose physiologic role remains to be more fully defined. We have found the region 
immediately upstream of the translated sequence highly conserved between the human 
and mouse homologs over more than 200bp. Confirmation of the role of these 
sequences in mediating MNC expression, as well as identification of potential CDP 
binding sites, awaits functional analysis of the promoter. 
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